Koninklijke Philips N.V.

NYSE:PHG

Medical - Devices

Healthcare
$29.81 +2.17%

+$0.57 today

Market cap
$29.11B
Beta
0.93
P/E (TTM)
23.1
EPS (TTM)
$1.02
Dividend yield
3.62%
52W Low $22.20High $33.44

Volume 1.45M

Average 1.17M

PHG Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Koninklijke Philips N.V.NYSE: PHG

Net Income · Q2 FY2026 · quarter ended Jun 2026

Net income grows, but more slowly than its trailing trend

Q2 FY2026 net income of €386M rose 59.5% year over year, behind the +541.7% change in trailing-twelve-month net income. Sequentially, it rose 151.5% from the prior quarter.

Context

  • Net income amounted to 5.0% of revenue in FY2025, unchanged from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 10 analysts of €1.6B (+78.6%) for the fiscal year ending Dec 2026, a slowdown from the +198.0% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
€386M+151.5% QoQ
Last fiscal yearDec 2025
€895M+198.0% YoY
LTMJun 2026
€1.12B+541.7% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+59.5%+86.8%+27.3 pp
1 year+198.0%+78.6%-119.4 pp
3-year CAGR—+26.5%—
5-year CAGR+18.8%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

EUR · from the cash flow

Latest · FY2025
895M EUR
Year-over-year change
+198.0%
4-year CAGR
+5.6%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How PHG compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +541.7% is the highest of 10, against a peer median of +19.3%.
  • Net income amounts to 6.3% of revenue for PHG, versus a peer median of 14.0%.
PHG Competitors
Net Income for PHG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABTAbbott LaboratoriesLTM Jun 2026$5.43B USD-61.2%-2.0%11.6%
MDTMedtronic plcLTM Jul 2026$5.27B USD+12.7%+8.5%14.0%
BSXBoston Scientific CorporationLTM Jun 2026$3.67B USD+34.6%+60.6%17.5%
RMDResMed Inc.LTM Jun 2026$2.66B USD+90.1%+19.3%47.1%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$2.04B USD-12.0%+3.4%10.1%
PHGKoninklijke Philips N.V.LTM Jun 2026€1.12B EUR+541.7%—6.3%
SNNSmith & Nephew plcFY2025$625M USD+51.7%+41.0%10.1%
LIVNLivaNova PLCLTM Sep 2026$196.07M USD+190.2%+41.2%13.0%
IRMDIRadimed CorporationLTM Mar 2026$23.61M USD+19.3%+20.6%27.4%
NPCENeuroPace, Inc.LTM Mar 2026$21.57M USD-13.1%-23.0%21.7%
Peer median (excluding PHG) —+19.3%+19.3%14.0%

Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income718.64M(1.7B)(492.99M)(912.95M)895M
Depreciation & Amortization1.32B1.6B1.26B1.39B1.13B
Deferred Income Tax00000
Stock-Based Compensation0000141M
Change in Working Capital(179.66M)(1.24B)1.51B7.57M(1.33B)
Accounts Receivables0(359.43M)322.17M(1.08M)(9M)
Inventory(686.73M)(601.16M)277.85M248.79M(115M)
Accounts Payables258.85M54.65M387.04M(630.63M)0
Other Working Capital248.22M(337.36M)518.94M390.49M(1.21B)
Other Non-Cash Items64.65M1.16B35.26M1.21B330M
Operating Cash Flow1.93B(181.82M)2.31B1.7B1.16B
Capital Expenditures(469.25M)(466.63M)(371.9M)(342.9M)(269M)
Acquisitions (Net)(3.5B)(600.11M)104.87M141.7M(3M)
Purchases of Investments(146.57M)(197.58M)(149.19M)(133.05M)0
Sales of Investments203.3M81.98M51.89M61.66M0
Other Investing Activities4.02B(12.61M)134.06M27.04M(465M)
Investing Cash Flow(317.95M)(1.58B)(553.53M)(633.87M)(737M)
Debt Repayment(296.68M)1.15B(195.68M)(88.7M)448M
Common Stock Issued27.19M12.61M000
Common Stock Repurchased(1.93B)(196.53M)(715.7M)(444.57M)0
Dividends Paid(569.71M)(433M)(2.16M)(1.08M)(328M)
Other Financing Activities(2.36M)(6.31M)(3.24M)(2.16M)(13M)
Financing Cash Flow(2.77B)525.49M(916.79M)(536.52M)107M
Effect of Forex Changes(162.77M)(136.41M)(25.17M)(105.14M)(139M)
Net Change in Cash(1.33B)(1.37B)813.77M421.64M393M
Free Cash Flow1.46B(648.45M)1.94B1.35B893M

Koninklijke Philips N.V.

NYSE:PHG

Intrinsic Alpha fair value

Locked

Current Price

$29.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.